July 18, 2007 - North American Scientific Inc. will showcase its ClearPath, a high-dose rate radiation treatment created for breast brachytherapy, aiming to enhance current accelerated partial breast irradiation (APBI) treatment options, at the 49th Annual Meeting of the American Association of Physicists in Medicine (AAPM), July 22-26, 2007 in Minneapolis, MN.
The Company’s multi-channel catheter system, which is inserted through a single incision, is designed to allow for low-dose or high-dose therapy. The ClearPath system reportedly offers physicians greater flexibility in treatment planning and dose optimization to the target region while minimizing exposure to nearby healthy tissue.
For more information: www.nasmedical.com